Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Comparison of Ruxolitinib , Momelotinib, and Pacritinib in the Inhibition of Immune Differentiation and Proliferation of T Cells in Myeloproliferative Neoplasm

Chi Chen, MD PhD, Hemant Sindhu, MD, Ajay Kundra, MD, Maryna Yarotska, MD, Tony W. Cheung, MD, Jen-Chin Wang, MD

Blood (2015) 126 (23): 5203.

https://doi.org/10.1182/blood.V126.23.5203.5203

Published: 2015

Journal Articles

Revisiting the IGF-1R Signaling Pathway in Myeloproliferative Neoplasms: Quantification of IGF-1 Receptor May be Useful in the Differential Diagnosis of Polycythemia

Guanfang Shi, PhD, Stacey Baptiste, MD, Maryna Yarotska, MD, Hemant Sindhu, MD, Ching Wong, MD, Madhumati Kalavar, MD, Vladimir Gotlieb, MD, Jen-Chin Wang, MD

Blood (2014) 124 (21): 3226.

https://doi.org/10.1182/blood.V124.21.3226.3226

Published: 2014

Journal Articles

Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression and Myeloid Derived Suppressor Cells (MDSC) In Myeloid Neoplasms Implicate The Mechanism Of IMiD Treatment Of Myelofibrosis

Ajay Kundra, MD, Stacey Baptiste, MD, Chi Chen, MD, Ph, D, Hemant Sindhu, MD, Jen-Chin Wang, MD

Blood (2013) 122 (21): 2837.

https://doi.org/10.1182/blood.V122.21.2837.2837

Published: 2013

Journal Articles

Immune Derangements in Patients with Myelofibrosis- the Role of T reg, Th17, and sIL2α

Hemant Sindhu, MD, Ajay Kundra, Chi Chen, MD, Ph.D, Jen-Chin Wang, MD

Blood (2012) 120 (21): 1763.

https://doi.org/10.1182/blood.V120.21.1763.1763

Published: 2012

Journal Articles

Changes of Megakaryocyte Gene Expression When Essential Thrombocythemia (ET) Transform Into Myelofibrosis (Post-ET MF) by Microarray Analysis,

Hemant Sindhu, MD, Chi Chen, MD, Ph.D, Muhammad I. Kafeel, MD, Yiwu Sun, MD, Ph D, Ching Wong, MD, Jen-Chin Wang, MD

Blood (2011) 118 (21): 3845.

https://doi.org/10.1182/blood.V118.21.3845.3845

Published: 2011

NARROW

Comparison of Ruxolitinib , Momelotinib, and Pacritinib in the Inhibition of Immune Differentiation and Proliferation of T Cells in Myeloproliferative Neoplasm

Revisiting the IGF-1R Signaling Pathway in Myeloproliferative Neoplasms: Quantification of IGF-1 Receptor May be Useful in the Differential Diagnosis of Polycythemia

Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression and Myeloid Derived Suppressor Cells (MDSC) In Myeloid Neoplasms Implicate The Mechanism Of IMiD Treatment Of Myelofibrosis

Immune Derangements in Patients with Myelofibrosis- the Role of T reg, Th17, and sIL2α

Changes of Megakaryocyte Gene Expression When Essential Thrombocythemia (ET) Transform Into Myelofibrosis (Post-ET MF) by Microarray Analysis,

Email alerts

ASH Publications

American Society of Hematology

Comparison of Ruxolitinib , Momelotinib, and Pacritinib in the Inhibition of Immune Differentiation and Proliferation of T Cells in Myeloproliferative Neoplasm

Revisiting the IGF-1R Signaling Pathway in Myeloproliferative Neoplasms: Quantification of IGF-1 Receptor May be Useful in the Differential Diagnosis of Polycythemia

Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression and Myeloid Derived Suppressor Cells (MDSC) In Myeloid Neoplasms Implicate The Mechanism Of IMiD Treatment Of Myelofibrosis

Immune Derangements in Patients with Myelofibrosis- the Role of T reg, Th17, and sIL2α

Changes of Megakaryocyte Gene Expression When Essential Thrombocythemia (ET) Transform Into Myelofibrosis (Post-ET MF) by Microarray Analysis,

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only